August 11th 2025
NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.
Supportive Psychotherapy in Everyday Clinical Practice: It’s Like Riding a Bicycle
May 24th 2017Supportive psychotherapy can serve as the first bridge out of social isolation and marginalization and addresses personality issues, such as deficits in character structure and defense mechanisms.
Read More
Depression and Anxiety Disorders in Patients With Cancer
March 31st 2017Psychiatrists need to understand the patient’s cancer diagnosis, staging, treatments and their adverse effects, and prognosis to appreciate the challenges the patient is coping with throughout treatment as well as survivorship or end-of-life.
Read More
Introduction: CAMs and the Future of Mental Health Care
November 30th 2016The articles in part 1 of this Special Report provide concise reviews of important research findings and clinical applications of mindfulness meditation, breath practices, and uses of CAM therapies for perinatal depression.
Read More
Perinatal Depression: An Evidence-Based Review of Integrative Treatment
November 30th 2016Many women choose to avoid standard treatment for perinatal depression, and instead prefer integrative treatments that incorporate complementary and alternative therapies. This article reviews the evidence base for these treatments.
Read More